FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
Liu C, Zhao Y, Wang J, Yang Y, Zhang Y, Qu X, Peng S, Yao Z, Zhao S, He B, Mi Q, Zhu Y, Liu X, Zou J, Zhang X, Du Q.
Liu C, et al. Among authors: yang y.
Cancer Lett. 2020 Feb 1;470:29-42. doi: 10.1016/j.canlet.2019.11.042. Epub 2019 Dec 4.
Cancer Lett. 2020.
PMID: 31811910